DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Wu L, Martinez-Castellanos MA, Quiroz-Mercado H. et al.
Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES).
Graefes Arch Clin Exp Ophthalmol 2008; 246: 81-87
We do not assume any responsibility for the contents of the web pages of other providers.